Articles tagged "Monitoring"

2019 American Transplant Congress
Integration Of Business Intelligence (BI) Solution In Tertiary Renal Transplant Centre To Drive Clinical Decisions.
M. Heer, S. Yausis, P. R. Trevillian
Newcastle Transplant Unit, John Hunter Hospital, Newcastle, Australia
*Purpose: The future of medicine will be enabled by big data. With the promise of data-driven knowledge and decision-making, innovative big-data projects are ongoing in…
2019 American Transplant Congress
Undernutrition is Associated with Impaired T Cell Protective Immunity in Pediatric Kidney Transplantation
E. T. Chambers¹, C. Chan¹, R. Ettenger², P. Grimm³, E. Reed², M. Sarwal⁴, L. Stempora⁵, B. Warshaw⁶, C. Zhao¹, O. Martinez⁷, A. Kirk⁵
¹Pediatrics, Duke University, Durham, NC, ²Pediatrics, UCLA, Los Angeles, CA, ³Pediatrics, Stanford, Palo Alto, CA, ⁴Pediatrics, UCSF, San Francisco, CA, ⁵Surgery, Duke University, Durham, NC, ⁶Pediatrics, Emory University, Atlanta, GA, ⁷Surgery, Stanford, Palo Alto, CA
*Purpose: Undernutrition has been associated with T cell immune cell dysfunction and infectious complications in non-immunosuppressed children. Thus, we aimed to define T cell phenotypes…
2019 American Transplant Congress
Utility of AlloSure Monitoring in Simultaneous Kidney and Pancreas Recipients
J. A. Klein, A. Gupta, P. Budhiraja, D. Cibrik
Nephrology, University of Kansas Medical Center, Kansas City, KS
*Purpose: Determine utility and efficacy of donor-derived cell free DNA (dd-cfDNA) monitoring in simultaneous kidney and pancreas (SPK) recipients compared to kidney transplant alone (KTA).…
2019 American Transplant Congress
Mortality around the One-Year Survival Metric after Liver Transplantation in the United States
C. Blebea¹, P. Chatterjee², A. Nathan¹, J. Diamond¹, H. J. Goldberg², A. Courtwright¹
¹Hospital of the University of Pennsylvania, Philadelphia, PA, ²Brigham and Women’s Hospital, Boston, MA
*Purpose: Liver transplant programs in the United States are evaluated on one-year survival, among other factors. This may create an unintended incentive to continue life-sustaining…
2018 American Transplant Congress
T Cell Immunomonitoring Including Donor Specific Treg Expansion Prospectively Predicts Renal Allograft Tolerance Induced by Transient Mixed Chimerism
K. Hotta, T. Oura, A. Dehnadi, K. Huh, M. Matsunami, H. Sasaki, G. Benichou, J. Madsen, A. Cosimi, T. Kawai.
Center for Transplant Science, Massachusetts General Hospital, Boston, MA.
Background: Successful induction of allograft tolerance in MHC-mismatched kidney transplantation has been achieved after induction of transient chimerism in both nonhuman primates (NHP) and humans.…
2018 American Transplant Congress
Follow-Up Care of Living Kidney Donors
N. Lam,¹ K. Lentine,² B. Hemmelgarn,³ S. Klarenbach,¹ R. Quinn,³ A. Lloyd,¹ S. Gourishankar,¹ A. Garg.⁴
¹University of Alberta, Edmonton, AB, Canada; ²Saint Louis University, St. Louis, MO; ³University of Calgary, Calgary, AB, Canada; ⁴Western University, London, ON, Canada.
The 2017 KDIGO guidelines recommend that living kidney donors receive lifelong annual follow-up care to assess renal health, including serum creatinine measurements with glomerular filtration…
2018 American Transplant Congress
CMV-Specific Cell-Mediated Immunity after Valgancyclovir Prophylaxis Predicts Late Onset CMV Infection in Kidney Transplant Patients
M. Jarque,¹ E. Crespo,¹ E. Melilli,² A. Manonelles,² N. Montero,² S. Luque,¹ J. Cruzado,^1,2 J. Grinyo,^1,2 O. Bestard.^1,2
¹Experimental Nephrology Laboratory, IDIBELL, Barcelona, Spain; ²Nephrology Department, Bellvitge University Hospital, Barcelona, Spain.
Background: There is currently no means to predict late-onset CMV infection after a long course of post-transplant Valgancyclovir prophylaxis therapy and its development still negatively…
2018 American Transplant Congress
Validation of the PROMIS-57 and PROMIS-29 Questionnaires in Kidney Transplant Recipients
E. Tang, A. Bansal, S. Cao, M. Li, M. Novak, I. Mucsi.
University Health Network, Toronto, Canada.
Background: The Patient Reported Outcomes Measurement Information System (PROMIS) provides generalizable and universal measures of various domains of patient reported outcomes. The PROMIS-57 and PROMIS-29…
2018 American Transplant Congress
Incidence of Epstein Barr Virus (EBV) DNAemia in EBV-Seronegative Solid Organ Transplant (SOT) Recipients with EBV-Seropositive Donors
C. Burton,¹ C. Mabilangan,² J. Preiksaitis.²
¹Pediatrics, University of Alberta, Edmonton, Canada; ²Medicine, University of Alberta, Edmonton, Canada.
Purpose: Since 2002, a pre-emptive approach to post-transplant lymhoproliferative disease prevention has been used at our center that includes EBV viral load (VL) monitoring in…
2018 American Transplant Congress
Benefit of Patient Portal Usage in Non-High Risk Kidney Transplant Recipients
A. Osband, J. Machan, P. Morrissey.
Surgery, Alpert Medical School of Brown University, Providence, RI.
Background: With widespread adoption of EHR (electronic health record), patients have access to a patient portal where they can view and thereby help monitor their…